Pediatrix Medical Group (NYSE:MD) Price Target Raised to $18.50 at UBS Group

Pediatrix Medical Group (NYSE:MD) had its price target raised by UBS Group from $16.50 to $18.50 in a report released on Friday,Benzinga reports. UBS Group currently has a neutral rating on the stock.

A number of other research analysts also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Mizuho boosted their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. Macquarie assumed coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. Finally, Truist Financial boosted their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Friday. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Trading Down 9.6 %

NYSE MD opened at $15.57 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. The company has a market capitalization of $1.34 billion, a price-to-earnings ratio of -5.09, a price-to-earnings-growth ratio of 1.43 and a beta of 1.57. The company’s 50-day simple moving average is $13.89 and its two-hundred day simple moving average is $12.96. Pediatrix Medical Group has a one year low of $6.62 and a one year high of $17.67.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The business had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. Equities analysts forecast that Pediatrix Medical Group will post 1.26 EPS for the current fiscal year.

Institutional Trading of Pediatrix Medical Group

Several institutional investors and hedge funds have recently bought and sold shares of the business. Quest Partners LLC lifted its stake in Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares during the period. Everence Capital Management Inc. lifted its stake in Pediatrix Medical Group by 7.5% during the 4th quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock valued at $182,000 after acquiring an additional 960 shares during the period. Parkside Financial Bank & Trust lifted its stake in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after purchasing an additional 1,040 shares during the period. Nomura Asset Management Co. Ltd. lifted its stake in shares of Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock valued at $33,000 after purchasing an additional 1,220 shares during the period. Finally, Quarry LP lifted its stake in shares of Pediatrix Medical Group by 54.1% in the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,662 shares during the period. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.